OBJ Limited signs suite of agreements with Proctor and Gamble

THE ROADHOUSE PHARMACY: OBJ Limited (ASX: OBJ) has entered into a suite of agreements with Procter and Gamble (P&G), the world’s largest consumer products company.

The agreements include a multi‐product development agreement (PDA) and an initial licensing agreement OBJ said sets the course to commercialise its magnetic micro‐array technology.

The PDA, Initial Licence and associated product development work plans comprise a multi‐product, multi‐category program that grants P&G world‐wide exclusive access to OBJ’s non‐powered micro‐array technology in specific consumer product categories.

The agreement package includes the over‐arching multi‐product and multi‐category PDA, the key terms of the master License that will apply to all new products developed under the PDA and work plans for the development of the first three products to utilize OBJ’s magnetic micro‐array technology, which includes the Initial Licence for the first of these products.

“The level of commitment over a number of years by the company’s key technical and management teams have been essential in achieving this important goal,” OBJ Limited non‐executive chairman Glyn Denison said in the company’s announcement to the Australian Securities Exchange.

Website: www.obj.com.au